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Available online 16 November 2013Abstract The aryl hydrocarbon receptor (AHR) is a transcription factor and environmental sensor that regulates expression of
genes involved in drug-metabolism and cell cycle regulation. Chromatin immunoprecipitation analyses, Ahr ablation in mice
and studies with orthologous genes in invertebrates suggest that AHR may also play a significant role in embryonic
development. To address this hypothesis, we studied the regulation of Ahr expression in mouse embryonic stem cells and their
differentiated progeny. In ES cells, interactions between OCT3/4, NANOG, SOX2 and Polycomb Group proteins at the Ahr
promoter repress AHR expression, which can also be repressed by ectopic expression of reprogramming factors in hepatoma
cells. In ES cells, unproductive RNA polymerase II binds at the Ahr transcription start site and drives the synthesis of short
abortive transcripts. Activation of Ahr expression during differentiation follows from reversal of repressive marks in Ahr
promoter chromatin, release of pluripotency factors and PcG proteins, binding of Sp factors, establishment of histone marks of
open chromatin, and engagement of active RNAPII to drive full-length RNA transcript elongation. Our results suggest that
reversible Ahr repression in ES cells holds the gene poised for expression and allows for a quick switch to activation during
embryonic development.
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AHR is a member of the bHLH/PAS family of transcription
factors and themainmediator of teratogenic and carcinogenic
toxicities resulting from exposure to planar polycyclic and
halogenated aromatic hydrocarbons present in the environ-
ment (Hankinson, 1995). Activation by ligand causes AHR to
translocate to the nucleus, dissociate from its cytosolic
chaperones and heterodimerize with its ARNT partner, also a
member of the bHLH/PAS family (Reyes et al., 1992). Binding
of AHR–ARNT complexes to AHR response motifs in the
promoters of target genes recruits transcription cofactors
and associated chromatin remodeling proteins and signals
initiation of gene transcription (Hestermann and Brown, 2003;
Schnekenburger et al., 2007). Increasing evidence indicates
that in addition to the well-known xenobiotic metabolism
genes in the Cyp1 family of cytochromes P450, there are other
AHR transcriptional targets, including genes involved in cell
cycle regulation and morphogenetic processes that may play a
vital function during embryonic development (Gasiewicz et
al., 2008; Sartor et al., 2009). Such a developmental role may
be an evolutionarily conserved primary function of the AHR, a
notion supported by the finding that unlike their vertebrate
counterparts, AHR orthologs in invertebrates like the fruit fly
Drosophila melanogaster and the nematode Caenorhabditis
elegans are not activated by xenobiotic ligands but control
expression of homeotic genes involved in neuronal speci-
fication during development (Emmons et al., 1999; Hahn,
2002; Qin and Powell-Coffman, 2004; Kim et al., 2006).
In mice, Ahr ablation leads to impaired vasculature in the
kidney, liver sinusoid, and eyes of the neonates (Lahvis
et al., 2000) with an ensuing cardiovascular disease that
might be directly or indirectly the principal cause of other
Ahr deficit phenotypes, such as reduced liver size, patent
ductus venosus, cardiac hypertrophy, hypertension, and fibro-
sis (Fernandez-Salguero et al., 1995, 1997; Lund et al., 2003,
2008; Lahvis et al., 2005).
Several studies have shown a complex pattern of Ahr
expression during early mouse embryogenesis. Fertilized
eggs at the 1-cell stage show detectable levels of Ahr mRNA
(Dey and Nebert, 1998; Wu et al., 2002) and high levels of
AHR activity, as determined by an elevated constitutive
mRNA level of the AHR target gene Cyp1a1 (Dey and Nebert,
1998). Thereafter, Ahr mRNA expression is completely
silenced between the 2- and 8-cell stages and afterwards
increases to a detectable level by late pre-implantation
blastocysts (Peters and Wiley, 1995; Dey and Nebert, 1998;
Wu et al., 2002). In the post-implantation embryo, Ahr
mRNA can be demonstrated as early as gestational day 9.5,
followed by widespread expansion into almost all developing
organs (Abbott et al., 1995; Jain et al., 1998).
Correct reprogramming of the epigenome during embryon-
ic preimplantation stages is essential for the acquisition of
pluripotency to ensure the concerted completion of develop-
ment. The above findings suggest that, concurrent with the
time of reprogramming of the embryonic epigenome and
establishment of pluripotency in the inner cell mass blasto-
cysts, embryos show low or undetectable levels of Ahr
expression. It is reasonable to hypothesize that, although
needed for post-implantation developmental stages, a func-
tional AHR might be detrimental to the preimplantation
process and needs to be silenced during this period.In ES cells, the pluripotency factors OCT3/4, NANOG and
SOX2 form a transcriptional network that controls the
expression of several hundred target genes, either by
activating the promoters of self-renewal genes or by
silencing the promoters of differentiation associated genes
(Christophersen and Helin, 2010). The specificity of this
silencing resides in the quick regulatory reversibility requir-
ing the interplay between core pluripotency factors,
numerous chromatin remodeling complexes, and paused
RNAPII molecules, that primes target genes and allows them
to be ready for fast activation when required by morphoge-
netic signals (Medvedev et al., 2012). The promoters of
these transcription factors are simultaneously marked by
active and repressive histone modifications (i.e., H3K4me3
and H3K27me3, respectively) (Mikkelsen et al., 2007) and
are repressed by Polycomb Group-mediated mechanisms,
including recognition by Polycomb repressive complexes
PRC-1 and -2 which further block transcript elongation by
RNAPII (Stock et al., 2007; Endoh et al., 2012). In this study,
we examine Ahr expression during in vitro non-directed
differentiation of mouse ES cells. We find that Ahr is silent in
these cells, but its expression is quickly restored upon
differentiation. ChIP analyses indicate that expression is
silenced by the binding of core pluripotency factors and PcG
proteins as well as pausing of RNAPII on the Ahr promoter.
These results are consistent with the concept that Ahr
silencing is required in ES cells and its expression needed for




Lists of primary antibodies and primers used in this work are
shown in Supplemental Tables S1 and S2.
Culture of embryonic stem cells and in vitro
differentiation
C57BL/6N-C2 mouse ES cells (Gertsenstein et al., 2010)
bearing the Ahrb-1 allele coding for the high ligand-affinity
Ah receptor were used throughout this study. Cells were
cultured in Dulbecco's Modified Essential Medium (Gibco,
Grand Island, NY) supplied with 15% (vol/vol) Knock-Out
Serum Replacement (KO-SR, Invitrogen, Grand Island, NY),
1000 units/ml ESGRO Leukemia Inhibitory Factor (LIF,
Millipore, Billlerica, MA), 50 units/ml penicillin, 50 μg/ml
streptomycin, 2 mM L-glutamine, 0.1 mM 2-mercaptoethanol,
0.1 mM MEM non-essential amino acids (NEAA, Invitrogen),
and 1 mM sodium pyruvate in a 5% CO2 humidified incubator at
37 °C. Tissue culture plates used for ES cells were coated with
0.1% gelatin at room temperature for 15 min. Plates with
feeder cells were prepared with mouse embryonic fibroblasts
pre-treated with 10 μg/ml mitomycin C (Sigma-Aldrich, St.
Louis, MO) plated at density of 5 × 104 cells/cm2. ES cells
were cultured either on gelatin coated plates or feeder plates
and passaged every second or third day. In vitro non-directed
differentiation (hereafter referred to as simply differentiation)
was initiated by forming embryoid bodies (EB) in differentiation
media either in 25-μl hanging drops (6 × 104 cells/ml) or in
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Differentiation medium was ES medium minus LIF and with FBS
instead of KO-SR. After 3 days of incubation, 100 EBs were
transferred per 10-cm tissue culture plate for use at various
time intervals.
Mouse hepatoma Hepa-1c1c7 (Hepa-1) cells from the
American Type Culture Collection were cultured in DMEM
supplemented with 5% (vol/vol) FBS in a 5% CO2 humidified
atmosphere at 37 °C. Cells were used for experiments when
they reached 70 to 80% confluence.Whole cell protein extraction and immunoblotting
Cells were harvested after washing twice with PBS. NETN
lysis buffer contained 100 mM NaCl, 20 mM Tris–HCl pH 8,
1 mM EDTA, 0.5% NP-40, and 1× complete protease inhibitor
cocktail (Roche, Indianapolis, IN). After lysis on ice for
10 min, lysates were sonicated for 2 min and centrifuged at
14,000 rpm at 4 °C for 10 min. Protein concentrations were
determined by the Bradford assay (Bio-Rad Protein Assay,
Bio-Rad, Hercules, CA). Twenty-five micrograms of protein
extract was subjected to SDS-polyacrylamide gel electro-
phoresis and transferred to a 0.45-μm polyvinylidene
fluoride membrane (Millipore). Immunoblotting was carried
out in TNT buffer containing 20 mM Tris–HCl pH 7.6, 137 mM
NaCl, and 0.1% Tween-20. After blocking with 5% non-fat dry
milk at room temperature for 2 h, membranes were probed
with the pertinent antibodies followed by species-specific
horseradish peroxidase-conjugated secondary antibodies
(Santa Cruz Biotechnology, Dallas, TX). After washing,
immunoblotting signals were visualized with chemilumines-
cence ECL Western Blotting Substrate (Pierce, Rockford, IL).Total RNA isolation, reverse transcription, and
real-time PCR reactions
Cells were lysed in Iso-RNA lysis reagent (5-Prime, Gaithers-
burg, MD) and RNAs were extracted according to the
manufacturer's specifications. Twenty micrograms of total
RNA and 20 pmol of random hexamer primer were denatured
at 70 °C for 5 min and allowed to cool. cDNA was prepared
with reverse transcription mix containing 1× reverse
transcriptase buffer, 15 μM dNTP, 10 mM DTT, 500 units of
Superscript III Reverse Transcriptase (Invitrogen), and
20 units of RNAsin (Promega, Madison, WI) at 42 °C for 2 h.
RNA was removed by treatment in 0.05 N NaOH, and after
neutralization cDNA was precipitated with ethanol in the
presence of 10 mg glycogen carrier and 300 mM sodium
acetate pH 5.2. Precipitates were dissolved in 200 μl ddH2O
and 1-μl aliquots were used per PCR reaction. Real-time PCR
reactions were done in duplicate in a total volume of 20 μl of
SYBR Green PCR Master Mix (Applied Biosystems, Grand
Island, NY) and 250 nM specific primers. Amplification used
an ABI 7500 (Applied Biosystems) with 1 cycle of 95 °C for
10 min and 40 cycles of 95 °C for 30 s and 60 °C for 1 min.
PCR efficiencies were verified by examination of the
corresponding melting curves for each primer pair. Data
were normalized to Gapdh mRNA standard relative to ES
cell expression and shown as ΔΔCt in log2 scale, where
ΔΔCt = (CtGene − CtGapdh)Assay − (CtGene − CtGapdh)ESC control.Immunofluorescence staining
Day 13 differentiated EB were cultured on 10-mm glass
coverslips, fixed with 4% paraformaldehyde in PBS for
20 min, permeabilized with 0.1% Triton X-100 for 20 min,
blocked with 1% BSA for 1 h, and incubated with first
antibody at 4 °C overnight. After washing, coverslips were
stained with Alexa 488- or Alexa 567-labeled secondary
antibodies and Hoechst solution. The cells were examined
and images were captured using a Zeiss Axio microscope.
Chromatin immunoprecipitation assay
Chromatin immunoprecipitation was done with minor modifi-
cations of our previously described procedures (Schnekenburger
et al., 2007). Cells were cross-linked with 1% formaldehyde at
room temperature for 10 min; after quenching the reaction by
adding 125 mM glycine at room temperature for 5 min, cells
were washed twice with cold PBS then scraped and harvested.
All solutions except the elution buffer contained 1× complete
protease inhibitor cocktail. Cell pellets were lysed in
Cell-Lysis-Buffer (5 mM PIPES pH 8.5, KCl 85 mM, and 0.5%
NP-40) on ice for 10 min; nuclei were pelleted and lysed in
Nuclei-Lysis-Buffer (50 mM Tris–HCl pH 8, 10 mM EDTA, and 1%
SDS) at an approximate density of 107 nuclei/ml followed by a
10-minute incubation on ice. Chromatin was sheared by
sonication with a Bioruptor (Diagenode, Denville, NJ) in a
crushed-ice water bath for thirty 30-second bursts of 200 W
with a 30-second interval between bursts. Supernatant was
collected after centrifugation and diluted 6× with
IP-Dilution-Buffer (16.7 mM Tris–HCl pH 8, 167 mM NaCl,
1.2 mMEDTA, 1.1% Triton X-100, and 0.01% SDS) and distributed
into aliquots corresponding to 2 × 106 cell-equivalents for each
ChIP assay. After pre-cleaning with a 50:50 mix of protein-A/
G-agarose (Upstate), 3 μg of the pertinent antibody was added
to each ChIP assay tube and incubated on a rotating platform at
4 °C overnight. Specific immune complexes were recovered by
a 2-hour incubation at 4 °C with 30 μl 50:50 protein-A/
G-agarose. Pelleted protein-A/G-agarose was washed three
times with 1×-Dialysis-Buffer (50 mM Tris–HCl pH 8, 2 mM
EDTA, 0.2% sarkosyl (omitted if the antibody was a mouse
monoclonal)) and three times with IP-Wash-Buffer (100 mM
Tris–HCl pH 9 (pH 8 for mouse monoclonal antibody), 500 mM
LiCl, 1% NP-40, 1% deoxycholic acid) on ice for 10 min.
Chromatin complexes were released by washing twice with
60 μl Elution-Buffer (50 mM NaHCO3 and 1% SDS) by vigorous
shaking in a vortex mixer for at least 20 min. Formaldehyde
cross-links were reversed and residual RNA removed by addition
of 300 mM NaCl and 20 μg RNAse A (Sigma) at 65 °C overnight.
ChIP-enriched DNA was purified by chromatography in a
QIAquick column (QIAGEN, Valencia, CA) after proteinase K
treatment at 45 °C for 1.5 h. The concentration of the purified
DNA was determined with PicoGreen dsDNA dye (Invitrogen)
and an aliquot was used for each PCR reaction. DNA enrichment
is represented as the percent of total input after subtracting the
values of the relevant control antibodies.
Induced expression of reprogramming factors
OCT3/4, SOX2, KLF4, and MYC in Hepa-1 cells
Hepa-1 cells at 70% confluence were transfected at 37 °C for 3 h
with plasmids pBabe-Puro, to provide puromycin resistance,
299Pluripotency factors repress Ah receptor expressionFUW-M2rtTA, to provide a source of tetracycline-activated
Tetracycline receptor, and TetO-FUW-OSKM (Addgene,
Cambridge, MA) (Carey et al., 2009), to provide
Tet-receptor dependent expression of OCT3/4, SOX2,
KLF4, and MYC. Transfection was by Lipofectamine 2000
and PLUS Reagent (Invitrogen) according to the
manufacturer's specifications. Transfected cells were incu-
bated for 3 h in medium containing 10% FBS and selected
with 3 μg/ml puromycin for 3 days. To activate the
expression of reprogramming factors coded for the
TetO-FUW-OSKM vector, 5 μg/ml doxycycline was added
to the cultures. Samples for mRNA and protein expression
analyses were collected after 3 days of puromycin selection
and doxycycline treatment.
Statistical analyses
All experiments were done in biological duplicates or
triplicates; data are presented as means ± SD. Group compar-
isons were made by two-way analysis of variance (ANOVA)
followed by Bonferroni post-test. A p-value equal to or less
than 0.05 was considered statistically significant.
Results
Ahr is silent in ES cells and its expression is
up-regulated upon differentiation
Previous work has shown that Ahr is expressed in fertilized
eggs (Dey and Nebert, 1998; Wu et al., 2002) but becomes
silent at the 2-cell stage, remaining completely silenced
until the late preimplantation stage, at what time blasto-
cysts begin to show detectable de novo Ahr expression
(Peters and Wiley, 1995; Dey and Nebert, 1998; Wu et al.,
2002). An expression pattern of quick reversibility such as
this is consistent with a developmental role for AHR that
might be harmful to the early preimplantation embryo but
needed for the late preimplantation and postimplantation
embryos. To investigate the mechanisms responsible for this
pattern of expression and identify what these functions
might be, we followed the temporal sequence of Ahr
expression in mouse ES cells, a ready source of in vitro
pluripotent preimplantation blastocysts and their differen-
tiated progeny. Relative to Gapdh, Ahr mRNA levels were
low but detectable in ES cells and increased with time of
differentiation, reaching maximal levels 9 days after initia-
tion of differentiation (Fig. 1A, upper panel). Starting on day
7, significant mRNA levels of the prototypical AHR target
gene Cyp1a1 were present (Fig. 1A, lower panel), suggestive
of endogenous AHR activation, independent of activation by
a xenobiotic ligand. AHR protein levels followed a similar
pattern of expression as the mRNA, reaching a maximum
after 7 days of differentiation (Fig. 1B).
Determination of mRNA levels of germ layer marker genes
(Fig. 1C) indicated that our non-directed differentiation
protocol generated a mixed population of differentiated
progeny in which all three cellular lineages, i.e. ectoderm,
mesoderm, and endoderm, were present, albeit possibly in
different proportions. Expression of AHR and its
co-localization with germ layer markers was also demonstrat-
ed by immunofluorescence staining of 13-day EBs, whichshowed that AHR independently co-localized with ectoderm
marker keratin 14, cardiac mesoderm marker troponin-T, and
endoderm marker Gata4 (Supplemental Fig. S1).
These data indicate that mechanisms exist to silence Ahr
transcription in ES cells and that differentiation in vitro
faithfully recapitulates the regulatory events of AHR
expression described earlier and previously observed in vivo.
Recruitment of Sp1 and Sp3 factors to the
proximal promoter up-regulates Ahr transcription
in differentiated cells
Constitutive Ahr expression depends on binding of Sp factors
to four Sp1 binding sites located between coordinates −174
and +70 from the TSS of the Ahr promoter (Fitzgerald et al.,
1998) (Figs. 2A, B). Ahr transcriptional silence may simply be
due to lack of functional expression of Sp-factors or to
impairment of chromatin binding in the ES cells but not in
the differentiated cells. To test this hypothesis, we used
ChIP analyses to measure binding of Sp-factors to their sites
in the Ahr proximal promoter and to compare pluripotent ES
cells to cells on day 9 of non-directed differentiation, at a
time when Ahr expression is maximal. Binding of Sp1 and
Sp3, already high in ES cells, doubled in the day 9 samples
(Fig. 2C, upper and middle panels), suggesting that the
promoter might be transcriptionally active under both
experimental conditions. However, this was clearly not the
case, since there was little if any AhrmRNA in the ES cells. In
agreement with gene silencing in ES cells, H3K36me3, a
histone mark associated with actively transcribed genes
(Bannister et al., 2005), was practically undetectable in ES
cells and significantly high in the differentiated cells
(Fig. 2C, lower panel), confirming that the Ahr promoter
proceeds from being silent to activated in parallel to the
differentiation of the ES cells.
Unproductive RNA polymerase II phosphorylated in
CTD-Ser-5 but not Ser-2 is paused on the Ahr proximal
promoter of ES cells
Changes in the phosphorylation of the RNAPII carboxyl-
terminal repeat domain (CTD) are associated with transcrip-
tional initiation, elongation and termination (Phatnani and
Greenleaf, 2006; Buratowski, 2009). Transcription initiation
without elongation leads to RNAPII pausing at transcriptional
start domains, a phenomenon first described in Drosophila
(Gilmour and Lis, 1986) and now recognized as a critical
mechanism to poise downstream target genes for rapid and
precise gene activation. While poised genes may lack RNAPII
binding or may bind RNAPII phosphorylated in Ser-5
(RNAPII-S5p+S2p−), active transcriptional elongation is gen-
erally characterized by RNAPII phosphorylated in both Ser-5
and Ser-2 (RNAPII-S5p+S2p+) (Stock et al., 2007; Brookes et
al., 2012). Studies in human and mouse ES cells have
revealed the prevalence of RNAPII-S5p+S2p− paused at
genes encoding proteins critical for developmental func-
tions, stimulus-responsiveness, and signaling components
that regulate ES pluripotency and self-renewal (Guenther et
al., 2007; Min et al., 2011; Gilchrist et al., 2012). Consistent
with our findings with Sp-factors and H3K36me3, binding of
RNAPII-S5p+S2p− on the Ahr proximal promoter was higher in
Figure 1 Ahr expression is silent in pluripotent mouse ES cells and activated during non-directed differentiation. After 3 days of EB
formation, differentiation was followed for 11 or 13 days on coverslips. Ahr and Cyp1a1 mRNA levels (A) were normalized to Gapdh
and are shown relative to the levels in ES cells (day 0). Immunoblots with AHR and β-actin specific primary antibodies (B) were
visualized with chemiluminescence ECL Western Blotting Substrate. (C) mRNA expression levels of pluripotency and germ cell layer
marker genes were examined by real time PCR, normalized to Gapdh and are shown relative to the levels in ES cells. The asterisk (*)
indicates significant differences to values in ES cells: (*) p b 0.05; (**) p b 0.01; and (***) p b 0.001.
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panel), suggesting that silent Ahr expression in ES cells
might be the consequence of an unproductive RNAPII form
paused on the proximal promoter domains. To test this
hypothesis, we measured the binding of the active form
RNAPII-S5p+S2p+ to the Ahr gene proximal promoter and
transcription end-site (TES) domains of ES and day 9
differentiated cells. Binding to the proximal promoter was
similar in ES and day 9 differentiated cells, but only the
differentiated cells showed significant binding of the active
RNAPII-S5p+S2p+ form to the TES domain (Fig. 2D, lower
panel), indicative of transcriptional elongation.Paused RNA polymerase II generates Ahr short
transcripts in ES cells
Increasing evidence from studies in a variety of systems,
including Drosophila and ES cells, indicates that the main
developmental checkpoint that directs differential gene
expression during differentiation is the regulation of
transcription elongation by release of tethered RNAPII from
the proximal promoter of the affected genes (Levine, 2011).
The paused RNAPII produces only short aborted transcripts,
while its release from the promoter results on full-length
transcript elongation (Rasmussen and Lis, 1995; Guenther et
al., 2007). To determine if the silent Ahr in ES cells produced
short transcripts absent in differentiated cells, we used
real-time RT-PCR to measure the number of increasingly
longer transcripts from the 5′-end of the mRNA (Fig. 2E)
relatives to the number of full-length molecules. We used
PCR primer pairs A–E (Fig. 2B and Table S2) to amplify, A:
the 5′-most 39, B: 50, and C: 97 nucleotides of AhrmRNA; D:
a 91-nucleotide segment from coordinates +55 to +146 from
exon 1; and, E: a 150-nucleotide segment bracketing exons 1and 2, from +5 to +155. The number of amplified molecules
for each of these amplicons was determined relative to the
number of amplified products of amplicon F, the
93-nucleotide segment bracketing exons 2 and 3 used to
assess the level of full-length transcription. In ES cells, short
Ahr transcripts were 8-fold more abundant than full-length
and their abundance decreased as the location of the PCR
amplicon proceeded 3′-ward, with much less transcripts
reaching position +155 (Fig. 2E, upper panel). In contrast, in
day 9 differentiated cells most transcripts were elongated
beyond +155 and hardly any short transcript was detected,
with 8-fold more full-length transcripts than in ES cells
(Fig. 2E, lower panel). These results confirm that pausing of
unproductive RNAPII on the Ahr proximal promoter gener-
ates short transcripts and that the transition from pluripo-
tent ES cell to differentiated cells is accompanied by a
switch in Ahr expression from repressed to active state.The core pluripotency factors OCT3/4, NANOG, and
SOX2 bind to the Ahr distal promoter domain
In ES cells, the three transcription factors OCT3/4, NANOG,
and SOX2 establish a regulatory network critical to maintain
pluripotency and self-renewal ability (Christophersen and
Helin, 2010). On the basis of their transcriptional status,
binding of these three factors characterizes promoters that
are active or primed for expression but repressed. On the
one hand, regulatory complexes of OCT3/4, NANOG, and
SOX2 activate and maintain the expression of pluripotency
genes, including themselves (Kim et al., 2008; Chambers and
Tomlinson, 2009); on the other hand, the same complexes
cooperate with Polycomb Group-mediated repressive mech-
anisms to keep developmentally regulated genes in a
repressed state (Boyer et al., 2006; Loh et al., 2006). By
Figure 2 Sp-factors and RNAPII control the transition of silent to activated Ahr. (A) Schematic representation of the mouse Ahr
gene and location of core pluripotency factors OCT3/4, SOX2, and NANOG and Sp1 binding sites along 5 kb of the Ahr promoter.
MatInspector software from GenoMatrix was used to screen binding sites of transcription factors. Blue, green, amber, and gray
squares represent OCT3/4, SOX2, and NANOG, and Sp1 binding sites respectively. (B) Location of primers used in this study. Upper
level: structure of the Ahr gene from 5 kb upstream of the TSS to the TES region. Middle level: expansion of the sequence from 3 kb
upstream of the TSS to the 2nd exon region. Lower level: expansion of the sequence from 1 kb upstream of the TSS to the 2nd exon.
Arrows indicate primers and target DNA strands, forward (f)/reverse (r) versus sense/antisense. (C) ES cells (blue bars) and cells
differentiated for 9 days (red bars) were compared for binding of Sp-factors (upper and middle panels) and active transcription
histone mark H3K36me3 (lower panel) on the Ahr proximal promoter region. (D) Binding of RNAPII-S5p+S2p− (upper panel) and
RNAPII-S5p+S2p+ (lower panel) on both the Ahr proximal promoter and the TES region. The asterisk (*) and the pound (#) denote
significant difference to ES or to day 9 differentiation, respectively: (*, #) p b 0.05; (**, ##) p b 0.001; and (***, ###) p b 0.001. (E)
The ratio of Ahr short transcripts to mature mRNA was determined as described in the text; the upper panel shows the ratio of
transcripts of various lengths in ES cells relative to mature mRNA in day 9 samples; the bottom panel shows the ratio of transcripts of
various lengths in day 9 samples relative to mature mRNA in ES cells.
301Pluripotency factors repress Ah receptor expressionscanning the 5 kb of Ahr promoter upstream of the TSS we
identified two clusters of pluripotency factor binding sites.
One cluster, located in the minus-3 kb region, comprises 2NANOG and 2 OCT3/4 binding motifs; the second, located in
the minus-2 kb region, contains 1 NANOG and 2 SOX2 motifs
(Fig. 2A). The presence of these motifs suggested the possibility
302 C.-I. Ko et al.that binding of OCT3/4-NANOG-SOX2 complexes to these sites
could be actively involved in repressing Ahr expression in ES
cells, a prediction that was confirmed by ChIP analyses. Binding
of OCT3/4 and SOX2 was observed primarily on the minus-2 kb
region and was significantly higher in ES cells than in day 9
differentiated cells (Figs. 3A, B). NANOG bound to both
minus-2 kb and minus-3 kb clusters, at levels significantly
higher in ES cells than in day 9 differentiated cells (Fig. 3C).
These results suggest that binding of pluripotency factors to the
Ahr promoter correlates with andmight significantly contribute
to its silencing in ES cells.H3K27ac, H3K9ac, H3K4me2 and H3K4me3 open
Ahr proximal promoter chromatin for expression
during differentiation
In addition to be repressed and primed for expression through
control of pluripotency factors, promoters of developmental
transcription factors are in a bivalent state, simultaneously
marked by active and repressive methylation and acetylation
marks in Lys-4, Lys-9 and Lys-27 (Mikkelsen et al., 2007). To
determine if the Ahr promoter had a characteristic pattern of
bivalent marks in ES cells that resolved after differentiation,
we examined the degree of acetylation and methylation of
H3K4, H3K9 and H3K27 in both distal and proximal Ahr
promoter domains. Total histone H3 acetylation and H3K9ac
were greatly increase in the day 9 differentiated cell
population relative to ES cells, particularly in the proximal
promoter, while H3K4ac and H3K27ac levels were similar in
both sets of cells (Figs. 4A–D, lower panels). In contrast to
acetylation, H3K27me1 and H3K27me2 were higher in the
differentiated cells, while H3K27me3 was not different in ES
and day 9 cells (Fig. 4B). Monomethylation of Lys-9 was very
high in ES cells, while dimethylation was higher in differen-
tiated cells and both sets of cells had similar levels of
trimethylated Lys-9 (Fig. 4C), a hallmark of heterochromatin
structure. Consistent with an active transcription state,
H3K4me3, H3K4me2 and H3K4me1 levels were much higherFigure 3 Binding of pluripotency factors to the Ahr distal promo
binding sites are located in the minus-3 kb, and minus-2 kb Ahr dom
bind to these sites to a significantly greater extent in ES cells than
differences between ES cells and day 9 differentiation: (#) p b 0.05in differentiated cells that in ES cells, especially in the
proximal promoter domains (Fig. 4D).
Binding of PcG proteins characterizes the bivalent
state of the Ahr promoter in ES cells
As described earlier, pluripotency factors cooperate with
reversible PcG-mediated mechanisms in the transcriptional
repression of differentiation associated genes in ES cells
(Bernstein et al., 2006). The reversibility of PcG-mediated
repression is provided by interactions between multiple protein
complexes, including PRC1, PRC2, and the Trithorax Group
(TxG) proteins, which are recruited to antagonize PcG effects
(Morey and Helin, 2010; Schuettengruber et al., 2011). To
further characterize Ahr repression in ES cells, we examined the
binding of several PcG and TxG proteins on the Ahr promoter.
Binding of (i) the PRC2 components EZH2, a H3K27 histone
methyltransferase, and SUZ12; (ii) the PRC1 component
RING1B, a H2AK119 E3 ubiquitin ligase; and (iii) MLL, a SET
domain TxG protein and H3K4 histone methylatransferase, was
higher in ES cells than in day 9 differentiated cells in all Ahr
promoter locations analyzed (Figs. 5A and top panel of B). The
same was true for the H3K27me3 demethylase KDM6B but not
for KDM6A (Fig. 5B, middle and bottom panels). It appears that
PcG/TxG interactions at the promoter are key to maintain the
Ahr gene in a repressed state in pluripotent ES cells.
Ectopic expression of reprogramming factors OCT3/
4, SOX2, KLF4, and MYC represses Ahr expression in
hepatoma cells
Major progress in stem cell biology has resulted from studies
that directly return somatic cells to the pluripotent state
by introduction of the so-called Yamanaka factors, namely
OCT3/4, SOX2, KLF4, and MYC (OSKM), which give rise to
induced pluripotent stem (iPS) cells from embryonic and/or
adult fibroblasts (Takahashi and Yamanaka, 2006). To deter-
mine whether expression of pluripotency factors could beter domain. As shown in Fig. 2, clusters of pluripotency factor
ains upstream of the TSS. OCT3/4 (A), SOX2 (B), and NANOG (C)
in day 9 differentiated cells. The pound (#) denotes significant
; (##) p b 0.01; and (###) p b 0.001.
Figure 4 Comparison of histone marks in the Ahr promoter in ES and day 9 differentiated cells. Levels of total histone H3
acetylation (panel A) and of mono-/di-/tri-methylated and acetylated H3K27, H3K9 and H3K4 (panels B, C and D, respectively) were
determined by chromatin immunoprecipitation in ES cells and day 9 differentiated cells. The asterisk (*) and the pound (#) denote
significant difference to ES or to day 9 differentiation: (*, #) p b 0.05; (**, ##) p b 0.001; and (***, ###) p b 0.001.
303Pluripotency factors repress Ah receptor expressionresponsible for Ahr repression in ES cells, we induced the
ectopic expression of a doxycycline-inducible OSKM expression
vector (Hockemeyer et al., 2008; Carey et al., 2009) in mouse
hepatoma Hepa-1 cells, which express high levels of AHR
protein, and measured the effect of OSKM expression on
AHR expression in the transfected cells. Three days after
transfection, Tet receptor dependent induction of ectopic
OCT3/4 and SOX2 was readily detectable in transfected cells,
possibly due to leakiness in the system, as already described
(Carey et al., 2009), and more so in cells treated with
doxycycline, in which expression reached levels comparable to
those in ES cells (Fig. 6A). In contrast, in the presence of OCT3/4
and SOX2, reduced levels of AHR protein, high in untransfected
cells, were detected; considerably lower in transfected cells
and less so in cells treated with doxycycline (Fig. 6A). When
immunoblot bands were quantified and normalized to β-actin
levels, it was evident that the low AHR and high OCT3/4-SOX2
levels observed in ES cells (Fig. 6B) were reversed in the
transfected Hepa-1 cells, in which even in the absence of
doxycycline treatment, AHR expressionwas inhibited by greater
than 15-times and more so after doxycycline treatment
(Fig. 6C). Consistent with the protein data, Ahr mRNA levels
were 3 times lower in transfected cells than in wild-type cells
(Fig. 6D). These data suggest that the pluripotency factorsOCT3/4 and SOX2 can repress Ahr expression and thus, may be
directly responsible for Ahr repression in ES cells.Discussion
The results from this study show that Ahr expression is
maintained in a repressed but poised state in pluripotent ES
cells that allows quick activation as the cells differentiate.
Repression results from the binding of a pluripotency factor
complex of OCT3/4-NANOG-SOX2 on the Ahr distal promoter
region in cooperation with other reversible regulatory mech-
anisms, including PcG-mediated repression and pausing of
unproductive RNAPII-S5p+S2p− molecules on the TSS proximal
promoter region. The switch of Ahr expression from repression
to activation follows the release of pluripotency factors from
their binding sites, withdrawal of PcG proteins, recruitment of
Sp-factors, acquisition of histone marks characteristic of open
chromatin on the proximal promoter region, and engagement
of phosphorylated RNAPII-S5p+S2p+ to drive full-length tran-
script elongation.
Our observations are consistent with previous findings in
vivo that Ahr expression is silenced at the 2-cell stage,
becoming again detectable in late blastocysts (Peters and
Figure 5 Binding of PcG and TxG proteins to the Ahr promoter. Binding profiles of PcG proteins EZH2, SUZ12, and RING1B (panel A) and
TxG proteins MLL, KDM6A and KDM6B (panel B) on both Ahr distal and proximal promoter regions. The asterisk (*) and the pound (#) denote
significant differences to ES or to day 9 differentiated cells respectively: (*, #) p b 0.05; (**, ##) p b 0.001; and (***, ###) p b 0.001.
304 C.-I. Ko et al.Wiley, 1995; Dey and Nebert, 1998; Wu et al., 2002) and in
most developing organs during post-implantation develop-
ment (Abbott and Probst, 1995; Jain et al., 1998). Such an
expression pattern suggests that AHR is developmentally
bivalent and that its functions during post-implantation must
be silenced if pluripotency is maintained. Studies on the
OCT3/4-NANOG-SOX2 regulatory network in ES cells have
shown that pluripotency factors maintain ES cell properties by
simultaneously activating expression of pluripotency-related
genes, including their own (Kim et al., 2008; Chambers and
Tomlinson, 2009) and repressing key differentiation transcrip-
tion factors (Boyer et al., 2006; Loh et al., 2006). Among the
latter, OCT3/4 was previously implicated on Ahr repression
(Loh et al., 2006). In good agreement, we find that, not just
OCT3/4, but NANOG and SOX2 as well are actively involved in
Ahr repression in ES cells through binding to their cognate sites
on the Ahr minus-2 kb distal promoter region. Ectopic OSKM
expression in mouse hepatoma Hepa-1 cells confirmed this
conclusion. Endogenous Ahr expression is very high in these
cells, but it was significantly repressed by the transfected
OSKM proteins both at the protein and mRNA levels. This
finding confirms that pluripotency factors are the main agents
of Ahr repression in pluripotent cells and suggests that Ahr
repression may be required to maintain pluripotency. In this
context, it may be significant that AHR regulates the
multipotency of hematopoietic stem cells, since its inhibition
promotes their greater expansion (Boitano et al., 2010), while
deletion of the Ahr gene increases the proliferative capacity
of hematopoietic progenitors (Lindsey and Papoutsakis, 2012;
Gasiewicz et al., 2010; Singh et al., 2011).Pluripotency factors do not act alone; they share
overlapping networks of target genes with PcG proteins
that further silence their targets (Bernstein et al., 2006;
Boyer et al., 2006; Loh et al., 2006). In ES cells,
differentiation associated genes are subject to flexible
epigenetic controls that repress and prime their expression
but do not fully silence them. Genes encoding transcription
factors that play an essential role during differentiation
carry bivalent promoter domain marks in ES cells, consisting
of active H3K4me3 and repressive H3K27me3 (Mikkelsen et
al., 2007). These marks, through their interplay with PcG
and TxG proteins, repress transcription but keep the genes
in a primed state (Morey and Helin, 2010; Schuettengruber
et al., 2011). The Ahr promoter does not show bivalent
domains in ES cells; in fact, in our hands and in good
agreement with previous studies (Mikkelsen et al., 2007; Ku
et al., 2008), H3K27me3 is low in both ES and differentiated
cells and H3K4me3 is low in ES cells and reaches high levels
in differentiated cells. Conversely, consistent with recent
work that has classified Ahr as a PcG-silenced gene (Brookes
et al., 2012), our ChIP analyses show that PcG-mediated
mechanisms are strongly involved in Ahr repression in ES
cells. Several PcG proteins, including EZH2, SUZ12, RING1B,
and TxG proteins MLL and KDM6B showed higher binding on
the Ahr promoter in ES than in differentiated cells. The E3
ubiquitin ligase activity of the PRC1 component RING1B
mediates pausing of unproductive RNAPII through
ubiquitination of histone H2A, contributing a key element
to gene repression (Endoh et al., 2012; Stock et al., 2007).
We conclude that, in addition to the inhibitory effect resulting
Figure 6 Doxycycline-induced expression of reprogramming factors in Hepa-1 cells represses AHR expression. Hepa-1 cells were
transfected with a rtTA-regulated doxycycline-inducible expression system of reprogramming factors (Oct3/4/SOX2/KLF4/MYC) (see
Materials and methods). Uninduced and 3-day doxycycline-induced transfected Hepa-1 cells and control ES cells were collected and
subjected to mRNA and protein expression analyses. Protein levels of AHR, OCT3/4 and SOX2 were determined in Western blots (panel
A) and quantified relative to β-actin levels for ES cells and Hepa-1 cells (panels B and C, respectively). Ahr mRNA levels in uninduced
and doxycycline-induced OSKM-transfected Hepa-1 cells are shown in panel D relative to the levels in untransfected cells. The
asterisk (*) and the pound (#) denote significant difference to untransfected or to uninduced Hepa-1 cells, respectively: (*, #)
p b 0.05; (**, ##) p b 0.001; and (***, ###) p b 0.001.
305Pluripotency factors repress Ah receptor expressionfrom direct binding of pluripotency factors, Ahr is also
repressed by PcG-mediated mechanisms. Binding of the two
TxG proteins, the H3K4 methyltransferase MLL and the H3K27
demethylase KDM6B, suggests that their role is to quickly
activate the Ahr upon reception of morphogenetic signals. The
main features of the transition of Ahr repression from
undifferentiated ES cells to activation in differentiated cells
are schematically presented in Fig. 7.Conclusions
Our observations are consistent with the concept that Ahr is
repressed in ES and conversely, rapid activation from the
silent state accompanies progression of differentiation. We
can only speculate as to what are the AHR functions that
need to be regulated by this concert of repression and
activation lest development be disrupted. Two of the most
prominent endogenous AHR functions are the inhibition ofTGFβ signaling pathways (Fan et al., 2010; Chang et al.,
2007) and the cooperation with the retinoblastoma protein
RB1 to promote cell cycle arrest (Puga et al., 2005). Given
the requirement for TGFβ-related signaling to maintain a
uniform population of proliferating undifferentiated ES cells
(Galvin-Burgess et al., 2013) and the impairment of
pluripotency when all three members of the retinoblastoma
family are ablated (Danneberg et al., 2000), it is attractive
to speculate that TGFβ and RB might be the targets of these
functions and that expression of a functional AHR in ES cells
might be detrimental to their survival but beneficial to their
differentiation.
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